First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients.
Zacherl MJ, Gildehaus FJ, Mittlmeier L, Böning G, Gosewisch A, Wenter V, Unterrainer M, Schmidt-Hegemann N, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H.
Zacherl MJ, et al. Among authors: kretschmer a.
J Nucl Med. 2021 May 10;62(5):669-674. doi: 10.2967/jnumed.120.251017. Epub 2020 Oct 2.
J Nucl Med. 2021.
PMID: 33008928
Free article.